《Table 1Characteristics of the 14 trials included in the meta-analysis.》
本系列图表出处文件名:随高清版一同展现
《Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis》
*Age expressed as mean±SD.**3 patients were subsequently excluded because of inability to comply with serial neurophysiological testing.MHE:minimal hepatic encephalopathy;HCV:hepatitis C virus;PSC:primary sclerosing cholangitis;AIH:autoimmune hepatitis;PB
Fourteen randomized controlled trials(combined n=1132)were included in this meta-analysis[5–9,12,15–22].The characteristics of 14 trials are summarized in Table 1.Seven trials(n=326)compared probiotic treatment with placebo or no treatment[5,6,12,15,20–22];three(n=276)compared the therapeutic effect of probiotics and lactulose[7,18,19];and four(n=530)compared probiotics with both placebo and lactulose[8,9,16,17].Each trial used different probiotics and doses(Table 2).All trials had a high risk of bias(Fig.2).However,the small number of the included trials limited the publication bias analysis.Hence,we only assessed groups that included five trails or more(Fig.3).
图表编号 | XD0020447100 严禁用于非法目的 |
---|---|
绘制时间 | 2018.02.01 |
作者 | Qing Cao、Cheng-Bo Yu、Shi-Gui Yang、Hong-Cui Cao、Ping Chen、Min Deng、Lan-Juan Li |
绘制单位 | State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital, Zhejiang University School of Medicine、State Key Laboratory for Diag |
更多格式 | 高清、无水印(增值服务) |